UY36171A - Derivados heteroaromáticos bicíclicos fusionados como inhibidores de quinasa - Google Patents
Derivados heteroaromáticos bicíclicos fusionados como inhibidores de quinasaInfo
- Publication number
- UY36171A UY36171A UY0001036171A UY36171A UY36171A UY 36171 A UY36171 A UY 36171A UY 0001036171 A UY0001036171 A UY 0001036171A UY 36171 A UY36171 A UY 36171A UY 36171 A UY36171 A UY 36171A
- Authority
- UY
- Uruguay
- Prior art keywords
- bicyclic heteroaromatic
- heteroaromatic derivatives
- derivatives fused
- inhibitors
- quinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Se proporciona una serie de derivados heteroaromáticos bicíclicos fusionados de fórmula (IA) o (IB), de acuerdo con lo definido en la presente memoria,que son inhibidores selectivos de actividad IIIß de fosfatidilinositol-4-quinasa (PI4KIIIß), son beneficiosos en el tratamiento y/o prevención de diversas dolencias humanas, que incluyen trastornos inflamatorios, autoinmunes u oncológicos; enfermedades virales y malaria; y el rechazo de trasplante de órganos o células.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1410816.1A GB201410816D0 (en) | 2014-06-17 | 2014-06-17 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
UY36171A true UY36171A (es) | 2016-01-29 |
Family
ID=51266752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001036171A UY36171A (es) | 2014-06-17 | 2015-06-16 | Derivados heteroaromáticos bicíclicos fusionados como inhibidores de quinasa |
Country Status (12)
Country | Link |
---|---|
US (2) | US9969748B2 (es) |
EP (1) | EP3157923A1 (es) |
JP (1) | JP2017518384A (es) |
CN (1) | CN106507674A (es) |
AR (1) | AR100894A1 (es) |
BR (1) | BR112016029630A2 (es) |
CA (1) | CA2950672A1 (es) |
GB (1) | GB201410816D0 (es) |
RU (1) | RU2017101324A (es) |
TW (1) | TW201625628A (es) |
UY (1) | UY36171A (es) |
WO (1) | WO2015193168A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017004133A1 (en) * | 2015-06-29 | 2017-01-05 | Nimbus Iris, Inc. | Irak inhibitors and uses thereof |
GB201517263D0 (en) | 2015-09-30 | 2015-11-11 | Ucb Biopharma Sprl And Katholieke Universiteit Leuven | Therapeutic agents |
GB201521767D0 (en) | 2015-12-10 | 2016-01-27 | Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R&D | Therapeutic agents |
EP3419980A4 (en) | 2016-02-26 | 2019-07-03 | The Board of Trustees of the Leland Stanford Junior University | INHIBITORS OF PI-KINASE WITH ANTI-INFECTIOUS ACTIVITY |
EP3511333B1 (en) * | 2016-11-23 | 2021-05-12 | Wuxi Fortune Pharmaceutical Co., Ltd | Crystal form and salt form of 7h-pyrrolo[2,3-d]pyrimidine compound and preparation method therefor |
CN109721531B (zh) * | 2017-10-27 | 2022-07-29 | 中国科学院合肥物质科学研究院 | 一种新型的脂质体激酶抑制剂 |
TWI795510B (zh) | 2018-01-17 | 2023-03-11 | 英商葛蘭素史密斯克藍智慧財產發展有限公司 | PI4KIIIβ抑制劑 |
MX2020013039A (es) | 2018-08-21 | 2021-02-26 | Kyorin Seiyaku Kk | Derivado de anillo heteroaromatico biciclico. |
AU2020241869A1 (en) * | 2019-03-21 | 2021-11-18 | The Board Of Trustees Of The Leland Stanford Junior University | PI4-kinase inhibitors and methods of using the same |
CN112592354B (zh) * | 2019-07-30 | 2022-05-27 | 厦门宝太生物科技股份有限公司 | 一种异噁唑并嘧啶类杂环化合物的制备方法 |
WO2021247809A1 (en) * | 2020-06-04 | 2021-12-09 | Merck Sharp & Dohme Corp. | PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CELLULAR PROLIFERATIVE DISORDERS |
WO2022028492A1 (en) * | 2020-08-05 | 2022-02-10 | Beigene, Ltd. | Imidazotriazine and pyrrolopyrimidine derivatives as kras g12c inhibitors |
WO2022067462A1 (en) * | 2020-09-29 | 2022-04-07 | Beigene (Beijing) Co., Ltd. | Process for preparing inhibitors of kras g12c |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1470356A1 (de) * | 1964-01-15 | 1970-04-30 | Thomae Gmbh Dr K | Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung |
DE2121950A1 (en) * | 1971-05-04 | 1972-11-23 | Dr. Karl Thomae Gmbh, 7950 Biberach | Thieno(3,2-d)pyrimidine derivs - with thrombocyte aggregation inhibiting activity |
RO62428A (fr) * | 1971-05-04 | 1978-01-15 | Thomae Gmbh Dr K | Procede pour la preparation des thyeno-(3,2-d)-pyrimidines |
WO2004092123A2 (en) | 2003-04-10 | 2004-10-28 | Microbia, Inc. | Inhibitors of fungal invasion |
US20080076924A1 (en) * | 2006-06-30 | 2008-03-27 | Patrick Betschmann | Piperazines as P2X7 antagonists |
JP2008012418A (ja) | 2006-07-05 | 2008-01-24 | Daikin Ind Ltd | プレフィルタ |
WO2009008906A2 (en) * | 2007-02-06 | 2009-01-15 | The Trustees Of The University Of Pennsylvania | Therapeutic compounds for blocking dna synthesis of pox viruses |
EP2022503B1 (de) | 2007-08-07 | 2011-10-19 | Symrise AG | Verkapselte Vacciniumextrakte mit ausgewogener Magen-Darm-Freisetzung |
WO2009038673A2 (en) * | 2007-09-14 | 2009-03-26 | Janssen Pharmaceutica N.V. | Thieno-and furo-pyrimidine modulators of the histamine h4 receptor |
AR083199A1 (es) * | 2010-09-29 | 2013-02-06 | Intervet Internationale B V | Compuestos de n-heteroarilo con unidad de puente ciclico |
MX2013003913A (es) * | 2010-10-08 | 2013-09-26 | Abbvie Inc | Compuestos de furo [3, 2-d] pirimidina. |
GB201114212D0 (en) * | 2011-08-18 | 2011-10-05 | Ucb Pharma Sa | Therapeutic agents |
GB201119401D0 (en) | 2011-11-10 | 2011-12-21 | Ucb Pharma Sa | Therapeutic agents |
CN104981247A (zh) * | 2012-09-06 | 2015-10-14 | 普莱希科公司 | 用于激酶调节的化合物和方法及其适应症 |
-
2014
- 2014-06-17 GB GBGB1410816.1A patent/GB201410816D0/en not_active Ceased
-
2015
- 2015-06-11 US US15/318,422 patent/US9969748B2/en not_active Expired - Fee Related
- 2015-06-11 RU RU2017101324A patent/RU2017101324A/ru not_active Application Discontinuation
- 2015-06-11 WO PCT/EP2015/063051 patent/WO2015193168A1/en active Application Filing
- 2015-06-11 CA CA2950672A patent/CA2950672A1/en not_active Abandoned
- 2015-06-11 BR BR112016029630A patent/BR112016029630A2/pt not_active IP Right Cessation
- 2015-06-11 CN CN201580032335.4A patent/CN106507674A/zh active Pending
- 2015-06-11 EP EP15727999.3A patent/EP3157923A1/en not_active Withdrawn
- 2015-06-11 JP JP2017518423A patent/JP2017518384A/ja active Pending
- 2015-06-15 TW TW104119305A patent/TW201625628A/zh unknown
- 2015-06-16 UY UY0001036171A patent/UY36171A/es not_active Application Discontinuation
- 2015-06-17 AR ARP150101940A patent/AR100894A1/es unknown
-
2018
- 2018-03-16 US US15/924,020 patent/US20180201622A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20180201622A1 (en) | 2018-07-19 |
TW201625628A (zh) | 2016-07-16 |
CN106507674A (zh) | 2017-03-15 |
US20170129905A1 (en) | 2017-05-11 |
AR100894A1 (es) | 2016-11-09 |
RU2017101324A3 (es) | 2018-12-27 |
US9969748B2 (en) | 2018-05-15 |
RU2017101324A (ru) | 2018-07-17 |
JP2017518384A (ja) | 2017-07-06 |
EP3157923A1 (en) | 2017-04-26 |
WO2015193168A1 (en) | 2015-12-23 |
BR112016029630A2 (pt) | 2017-08-22 |
CA2950672A1 (en) | 2015-12-23 |
GB201410816D0 (en) | 2014-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY36171A (es) | Derivados heteroaromáticos bicíclicos fusionados como inhibidores de quinasa | |
CY1123142T1 (el) | Βελτιωμενες μεθοδοι για την παραγωγη θετων κυτταρικων θεραπειων | |
CL2017002123A1 (es) | Heterociclos biciclicos como inhibidores de fgnr | |
CL2016002394A1 (es) | Derivados de quinolina como inhibidores de smo | |
ECSP15048555A (es) | Heterociclos bicíclicos como inhibidores de fgfr | |
CY1119840T1 (el) | Δικυκλικως υποκατεστημενες ουρακιλες και η χρηση αυτων | |
MX2017007641A (es) | Conjugados de anticuerpo-farmaco con inhibidores de bcl-xl permeables en las celulas. | |
TWD175457S (zh) | 耳環 | |
TWD170356S (zh) | 項鍊 | |
BR112016016158A2 (pt) | Derivados de heterociclila bicíclicos como inibidores de irak4, sua composição farmacêutica e seus usos | |
BR112017001058A2 (pt) | inibidores derivados de 2-h-indazole como quinase ciclina dependente (cdk) e seus usos terapêuticos | |
MY192927A (en) | Fused bicyclic compounds for the treatment of disease | |
CL2017001661A1 (es) | Compuestos biciclicos fusionados para el tratamiento de una enfermedad. | |
EP3223829A4 (en) | Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies | |
TWD177712S (zh) | 置物架 | |
BR112016029632A2 (pt) | derivados heteroaromáticos bicíclicos fundidos como inibidores de cinase | |
EA201691887A1 (ru) | Лечение внутрипеченочных холестатических заболеваний | |
CO2017005732A2 (es) | Compuestos de dihidropirimidin-2-ona y sus usos médicos | |
DK3189844T3 (da) | Pluripotent stamcelle til behandling af diabetisk hudsår | |
UA112488C2 (uk) | Три(гетеро)арилпіразоли і їх застосування | |
EP3439610A4 (en) | THERAPEUTIC USE OF ELECTROACUPUNCTURE INDUCED MESENCHYMAL STEM CELLS | |
TWD181311S (zh) | 安全護目鏡 | |
TWD177392S (zh) | 飾品 | |
TWD180406S (zh) | 拋棄式尿布 | |
TWD171457S (zh) | 耳環 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20220620 |